SCHEMBL5571397

SCHEMBL5571397

CS(=O)(=O)N(C(=O)c1ccccc1Cl)c1ccc(C(=O)NCc2ccc3c(c2)OCO3)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
PKM P14618 2/20 0.61
MAPT P10636 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
TDP1 Q9NUW8 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
LMNA P02545 2/20 0.55
MAPK1 P28482 1/20 0.55
MMP13 P45452 1/20 0.55
ALDH2 P05091 1/20 0.55
TP53 P04637 1/20 0.54
HSD17B10 Q99714 1/20 0.54
HSP90AA1 P07900 1/20 0.53
HPGD P15428 1/20 0.53
TSHR P16473 1/20 0.53
POLB P06746 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767807 0.84 NPSR1 (0.74) ALDH1A1PKMMAPTNPSR1MEN1
SCHEMBL5571398 0.81 NPC1 (0.47) ALDH1A1MAPTNPSR1SMN1; SMN2LMNA
SCHEMBL5571868 0.78 ALDH1A1 (0.58) ALDH1A1PKMMAPTNPSR1MEN1
SCHEMBL4791474 0.78 ALDH1A1 (0.61) ALDH1A1PKMMAPTNPSR1MEN1
SCHEMBL4925396 0.75 MEN1 (0.84) ALDH1A1PKMMAPTMEN1KMT2A
SCHEMBL10107742 0.75 ALDH2 (0.77) ALDH1A1MAPTMEN1KMT2ATDP1
SCHEMBL4767802 0.73 KMT2A (0.64) ALDH1A1PKMMAPTMEN1KMT2A
SCHEMBL5335238 0.73 MEN1 (1.00) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL108263 0.73 ALDH1A1 (0.92) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL503808 0.72 ALDH2 (1.00) ALDH1A1MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 ALDH1A1 2159/4885PKM 932/4885MAPT 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.